This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Assistance Publique-Hopitaux De Paris. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovator Minh Tam Baylatry and His Pioneering Injectable Biomaterial
Introduction
Minh Tam Baylatry is a notable inventor based in Paris, France, recognized for his significant contributions to the field of biomaterials. With a keen interest in medical innovations, he has developed a unique injectable biomaterial that has the potential to revolutionize treatments for various medical conditions.
Latest Patents
Baylatry holds one patent for an injectable biomaterial. This innovative product contains a non-aqueous solvent suitable for injection into humans and incorporates nanoparticles made of a polymer that is both insoluble in water and the solvent used. These nanoparticles are designed to be loaded with a drug or biological agent, making the injectable biomaterial suitable for occluding normal or malformative blood vessels, non-circulating cavities, or for necrosing tumors.
Career Highlights
Minh Tam Baylatry is currently affiliated with Assistance Publique-Hôpitaux de Paris, a prestigious hospital group in France. His work there involves collaborating on cutting-edge research aimed at improving patient care through innovative medical solutions.
Collaborations
Throughout his career, Baylatry has collaborated with esteemed colleagues such as Anouk Bisdorf-Bresson and Denis Labarre. These partnerships have not only enhanced his research projects but have also contributed to advancing the field of biomaterials.
Conclusion
Minh Tam Baylatry's work exemplifies the spirit of innovation in the medical field. His development of an injectable biomaterial highlights the importance of integrating technology and medicine to improve health outcomes. As he continues his work at Assistance Publique-Hôpitaux de Paris, the contributions of inventors like Baylatry will undoubtedly pave the way for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
